The market offers a range of Red Yeast Rice (RYR) products which are classified either as Chinese Proprietary Medicine (CPM) or Dietary Supplements.
RYR products that falls under the category of CPM require registration and approval by HSA1 prior to importation, manufacture and sales in Singapore.
On the other hand, RYR products under the category of dietary supplements are not subjected to the approval and licensing by HSA2.
It is advisable for consumers to choose a RYR product that offers assurance based on its own merits. Key considerations when choosing a RYR product are:
- whether the active ingredient used in the product is standardized; and
- whether clinical evidence of safety and efficacy is available
Standardization is crucial to achieve consistency and quality in every batch of the particular RYR product in order to ensure that it will produce reliable clinical results.
The presence of clinical evidence of a RYR product provides assurance that it has undergone testing and is able to support its claims on safety and efficacy.
It is important to choose a RYR product made with standardized active ingredients that has undergone stringent quality control measures throughout the manufacturing processes to ensure safety, efficacy, integrity and consistency.
References
